Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pall Corporation is a global leader in high-tech filtration, separation, and purification solutions, serving the diverse needs of customers across the broad spectrum of life sciences and industry. The company's Life Sciences division provides cutting-edge technologies for the development and manufacture of biological drugs, including monoclonal antibodies, vaccines, and advanced cell and gene therapies. The Dordrecht facility in the Netherlands serves as a key manufacturing and distribution hub for Pall's bioprocessing technologies, specializing in high-performance filtration products. As a subsidiary of Danaher Corporation, Pall integrates its expertise into a comprehensive portfolio of science and technology innovations designed to improve health and safety worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pal Dordrecht.